About the West London Haemoglobinopathy Coordinating Centres (HCC)
Sickle Cell Disease (SCD) is an inherited blood disorder that affects haemoglobin, the component of blood that transports oxygen. People who have this condition require specialist care throughout their lives. The disorder mainly affects black and minority ethnic populations which often have poorer health outcomes.
The prevalence of haemoglobinopathies across England varies widely, with the majority of patients concentrated around urban areas, as does the expertise to manage these conditions. London centres report that they treat 8726 patients (March 2018), not including those from neighbouring areas that are part of the London ODNs, which translates to 62% of all registered haemoglobinopathy patients.
Meet the team
Our team of dedicated professionals, committed to advancing care and support for individuals with Sickle Cell Disease, Thalassaemia, and other red cell disorders.
What we do
The West London HCC is dedicated to improving care for those with Sickle Cell Disease, Thalassaemia, and other rare anaemias through education, multi-disciplinary collaboration, governance, and patient involvement.
Hospitals in our network
Explore the West London Sickle Cell Network and get familiar with the comprehensive care available to support your journey.
Patient Public Involvement (PPI)
The public and patient voice group plays a central role in shaping the work of the West London Haemoglobinopathy Coordinating Centre (HCC).
Anti-racism statement
At West London, we stand firmly against racism in all its forms. We understand the profound and harmful effects that racism has on the lives of our patients and are committed to ensuring everyone feels safe, respected, and supported when accessing our care.
Annual reports
Explore the annual reports from the West London Haemoglobinopathy Coordinating Centre (WLHCC).
